These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 38169336

  • 1. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019.
    Deep A, Alexander EC, Khatri A, Kumari N, Sudheendhra K, Patel P, Joarder A, Elghuwael I.
    Pediatr Crit Care Med; 2024 Jan 01; 25(1):15-23. PubMed ID: 38169336
    [Abstract] [Full Text] [Related]

  • 2. A Comparison of the Anticoagulation Efficacy and Safety of Epoprostenol to Heparin and Citrate in Children Receiving Continuous Renal Replacement Therapy.
    Sondhi E, Stewart M, Harper J, Konyk L, McSteen C, Crowley KL, Kim-Campbell N, Fabio A, Fuhrman DY.
    Blood Purif; 2024 Jan 01; 53(10):838-846. PubMed ID: 38991509
    [Abstract] [Full Text] [Related]

  • 3. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct 01; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P.
    Crit Care; 2023 Jun 07; 27(1):222. PubMed ID: 37287084
    [Abstract] [Full Text] [Related]

  • 5. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Jun 07; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 6. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A.
    PLoS One; 2017 Jun 07; 12(8):e0182134. PubMed ID: 28792509
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y.
    Cochrane Database Syst Rev; 2020 Mar 13; 3(3):CD012467. PubMed ID: 32164041
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y.
    Cochrane Database Syst Rev; 2020 Dec 14; 12(12):CD012467. PubMed ID: 33314078
    [Abstract] [Full Text] [Related]

  • 9. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G, Demirbuga A, Annayev A, Citak A.
    Int J Artif Organs; 2020 Apr 14; 43(4):234-241. PubMed ID: 31856634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE.
    Crit Care; 2021 Aug 19; 25(1):299. PubMed ID: 34412667
    [Abstract] [Full Text] [Related]

  • 12. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr 19; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.
    Zhu D, He J, Xiao Z, Zhou X, Zhang X.
    Sci Rep; 2024 Jun 12; 14(1):13504. PubMed ID: 38866989
    [Abstract] [Full Text] [Related]

  • 16. Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation.
    Giani M, Scaravilli V, Stefanini F, Valsecchi G, Rona R, Grasselli G, Bellani G, Pesenti AM, Foti G.
    ASAIO J; 2020 Mar 12; 66(3):332-338. PubMed ID: 31045918
    [Abstract] [Full Text] [Related]

  • 17. Single-dose application of antithrombin as a potential alternative anticoagulant during continuous renal replacement therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis.
    Brunner R, Leiss W, Madl C, Druml W, Holzinger U.
    Anesth Analg; 2013 Mar 12; 116(3):527-32. PubMed ID: 23400980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.
    Boldt D, Busse L, Chawla LS, Flannery AH, Khanna A, Neyra JA, Palmer P, Wilson J, Yessayan L.
    Ren Fail; 2023 Mar 12; 45(2):2290932. PubMed ID: 38073554
    [Abstract] [Full Text] [Related]

  • 20. Renal replacement therapy and anticoagulation.
    Brandenburger T, Dimski T, Slowinski T, Kindgen-Milles D.
    Best Pract Res Clin Anaesthesiol; 2017 Sep 12; 31(3):387-401. PubMed ID: 29248145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.